Supraventricular Tachycardia Management – A Treatment Comparison Study

Calcium Channel Blockers versus Beta Blockers in the Chronic Management of SVT in Pediatric Subjects without Pre-excitation Syndrome or Hemodynamically Significant Heart Disease

Protocol Description

This study seeks to compare the known efficacy and adverse effects of calcium channel blocker therapy as compared to beta blocker therapy when used for the chronic treatment of non-preexcited supraventricular tachycardia (SVT) in patients without hemodynamically significant heart disease.

Eligibility Criteria

The study will evaluate the medical records of patients who were age 1 to 21 at the time of their diagnosis of SVT.
Males and Females: Ages 1 through age 21


There are no requirements for participants. Clinical data is taken from the medical record for review and analysis.
Visits: None required
Duration: Not applicable

Status: Enrolls from Current Patient Cases

Primary Investigator

Gaurav Arora, MD

Contact Information

For more information about the study, please contact:
Clinical Research Manager David Groscost, MSHA, RN